Enhanced Precision Kits for Quantitative Proteomics

PeptiQuant™ Plus

These kits offer our widest panels — each kit includes multiplexed assays for up to 125 proteins in human or mouse plasma.

The PeptiQuant™ Plus Proteomics kits provide a thorough MRM-MS strategy with paired labeled and unlabeled peptide standards to ensure robust, reproducible, and interference-free measurements. These easy-to-use kits enable you to perform precise protein quantitation using your own in-house LC-MS/MS instrumentation. Whether you’re interested in cancer, CVD, or other research areas, our carefully selected panels are able to assist your research needs.

Technology

Paired heavy/light peptide quantitation strategy

PeptiQuant™ Plus Proteomics Kits

PeptiQuant™ Plus Proteomics Kit for Human Plasma

PeptiQuant™ Plus Proteomics Kit for Mouse Plasma

Uses high quality MRM-MS technology to simultaneously quantify up to 125 human or mouse proteins from a single plasma sample! Comprehensive internal standards ensure accurate quantitation. The panel includes medium to low abundance proteins associated with cancer, CVD, and other diseases.

Features

Our largest protein panel yet. Simultaneously quantify 125 proteins from a single plasma sample!

Available for human or mouse plasma

Available for a wide variety of triple quadrupole mass spectrometers

Panel includes low abundance proteins associated with cancer, CVD, and other diseases

High quality MRM-MS technology, with all assays characterized according to Tier II CPTAC guidelines

High purity paired heavy/light peptide standards for every targeted protein

Compatible with sample volumes as low as 10 µl of plasma

A complete turnkey solution for quantitative proteomics

Each kit includes

Heavy SIS and light peptide standard mixes

Includes BSA and trypsin

Quality control samples

Kit Manual with all required SOPs

USB with all required acquisition methods and worklists for selected instrument

Analysis instructions with Skyline templates for automated data analysis

How to order

PeptiQuant™ Plus kits can be ordered directly through our online shop as well as through our partner Cambridge Isotope Laboratories Inc.

Our complementary line of quality control products will help to ensure that your proteomics workflow and instrumentation is up to standard for every sample you analyze.

PeptiQuant™ Plus technology is also offered in a full-service format, allowing for quantitation of up to 375 proteins in a single multiplexed analysis.

ASSOCIATED REFERENCES

Jun 2018

Michaud SA, Sinclair NJ, Petrošová H, Palmer AL, Pistawka AJ, Zhang S, Hardie DB, Mohammed Y, Eshghi A, Richard VR, Sickmann A, Borchers CH

May 2017

LeBlanc A, Michaud SA, Percy AJ, Hardie DB, Yang J, Sinclair NJ, Proudfoot JI, Pistawka A, Smith DS, Borchers CH

Dec 2016

Percy AJ, Yang J, Chambers AG, Mohammed Y, Miliotis T, Borchers CH

Sep 2016

Percy AJ, Michaud SA, Jardim A, Sinclair NJ, Zhang S, Mohammed Y, Palmer AL, Hardie DB, Yang J, LeBlanc AM, Borchers CH

Sep 2016

Mohammed Y, Bhowmick P, Smith DS, Domanski D, Jackson AM, Michaud SA, Malchow S, Percy AJ, Chambers AG, Palmer A, Zhang S, Sickmann A, Borchers CH

Read more about what makes our technology unique.

Shop for kits, request more information, or read our FAQ.

PeptiQuant™ kits not quite right for you? Let us take care of analysis with our PeptiQuant™ services.

Targeted mass spectrometry assays were characterized at the UVic-Genome BC Proteomics Centre according to the National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) assay characterization guidelines (https://assays.cancer.gov/guidance-document). Initial characterization data (produced in a human plasma matrix), can be viewed on the CPTAC Assay Portal (https://assays.cancer.gov). Note: Specific kits may use a different type of matrix from the human plasma that was used to generate the CPTAC fit-for-purpose characterization data, and thus assay performance from this kit may vary from that reported on the CPTAC Assay Portal. The CPTAC assay characterization guidance documents were developed as a direct outcome of a workshop (Carr et al., Mol Cell Proteomics 2014; PMID 24443746) sponsored by the CPTAC program.